Skip to main content

Perfusion Systems Market Report [2021-2028] | Size, Share, Growth, Trends, Competitive Landscape, Revenue, Forecast Analysis

The major companies in the global the perfusion systems market are Medtronic, GENERAL ELECTRIC COMPANY, Organ Assist Products B.V., Accuray Incorporated, Siemens Healthcare Private Limited, Shimadzu Corporation, Samsung Medison Co., Ltd., Hitachi, Ltd., XVIVO Perfusion AB, and other prominent players.

Pune, India, Oct. 08, 2021 (GLOBE NEWSWIRE) — The global perfusion systems market size is expected to gain momentum owing to the rising number of organ transplantation during the forecast period. This information is published by Fortune Business Insights™ in an upcoming report, titled, “Perfusion Systems Market, 2021-2028.” The rising prevalence of organ transplant patients, geriatric population, chronic diseases, automation, lifestyle disorders, healthcare infrastructure, and government initiatives are some of the major driving factors.

For instance, according to Organ Donation and Transplantation, 36500 transplants were performed in the U.S. alone, and 121,678 transplantation procedures were planned, out of which 100,791 were kidney transplants in 2018.


Request a Sample Copy of the Research Report:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/perfusion-systems-market-103497


COVID-19 Impact-

Negative Impact of Covid-19 on Medical Treatment

The COVID-19 epidemic has redirected financial resources from healthcare services for perfusion systems around the world. COVID-19 also causes organ malfunction, which makes it challenging to arrange a transplant. The outbreak of COVID-19 in most countries around the world has been altered to accommodate the situation and reduce patients’ exposure to the virus for perfusion systems.

Segments-

By technique, the market is segmented into hypothermic, and normothermic. On the basis of organs, the market is segregated into lungs, heart, and others. On the basis of product, the market is categorized into cardiopulmonary perfusion systems includes oxygenation systems, heart-lung machines, cooling and heating devices, blood parameter monitoring system, centrifugal blood pump systems, and others, extracorporeal membrane oxygenation, isolated organ perfusion systems, and others. On the basis of end-user, the market is fragmented into hospitals, clinics, ambulatory surgicalcenterss, and others. Finally, by geography, the market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.


To get the short-term and long-term impact of COVID-19 on this Market.

Please visit:https://www.fortunebusinessinsights.com/perfusion-systems-market-103497


What does the Report Offer?

The report for particle therapy also includes a comprehensive analysis of developing trends and new innovative solutions. The report covers the comprehensive methodological approach, which includes primary interviews and secondary research.

Increasing Number of Chronic Diseases to Stimulate Growth

The global perfusion systems market growth is expected to grow due to the rising R&D during the projected period. The increasing need for organ transplants as a result of the increasing frequency of chronic diseases is a major driver driving market expansion. Furthermore, an increase in the incidence of organ failures is increasing the needs for cost-effective methods. The potential for transplantation of other organs, such as the liver, is now being investigated. It helps drain proteins, poisons, and cytokines from the liver by providing a constant supply of antioxidant properties and metabolic substrates. This reduces the damage caused by reperfusion in a statically stored liver.

Increasing Healthcare Expenditure to Promote Growth in North America

North America is expected to hold the largest global perfusion systems market share during the forecast period. This is due to an increasing number of organ donors, healthcare expenditure, and advantageous healthcare policies driving the region’s market.

Asia Pacific is anticipated to hold a significant position in the market. The increasing prevalence of chronic diseases, and the demand for organ donation, governments in both rich and developing countries are encouraging people to donate organs to help with transplant surgery.


Have Any Query? Ask Our Experts: 

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/perfusion-systems-market-103497


Key Players Focus on Partnership to Strengthen their Market Position

The market is competitive, with leading competitors investing in ongoing product development and collaboration partnerships. The growing number of system distributors and dealers is projected to increase industry competition in the coming years for perfusion systems.

Industry Development-

  • May 2019: Terumo Cardiovascular Group teamed up with Talis Clinical to launch ACG-Perfusion and ACG- RemoteView systems in North America.


List of Key Players Profiled in the Global Market for Perfusion Systems:

  • Medtronic
  • GENERAL ELECTRIC COMPANY
  • Organ Assist Products B.V.
  • Accuracy Incorporated
  • Siemens Healthcare Private Limited
  • Shimadzu Corporation
  • Samsung Medison CO.
  • Hitachi Ltd.
  • XVIVO Perfusion AB


Global Perfusion Systems Market Segmentation :

By Technique

  • Hypothermic
  • Normothermic

By Organ

  • Heart
  • Lung
  • Others

By Product

  • Cardiopulmonary Perfusion System
  • Oxygenation Systems
  • Heart-lung Machines
  • Cooling and Heating Devices
  • Blood Parameter Monitoring Systems
  • Centrifugal Blood Pump Systems
  • Others
  • Extracorporeal membrane oxygenation (ECMO)
  • Isolated Organ Perfusion Systems
  • Others

By End-user

  • Hospital
  • Clinic
  • Ambulatory Surgical Centers
  • Others

By Geography

  • North America (USA, Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, Rest of Latin America)
  • Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)


Ask for Customization of this Report:

https://www.fortunebusinessinsights.com/perfusion-systems-market-103497


About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.


Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

LinkedIn: https://www.linkedin.com/company/fortune-business-insights

Facebook: https://www.facebook.com/FortuneBusinessInsightsPvtLtd

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.